References
- Foundation Ba Mg. Annual letter from Bill Gates. Bill and Melinda Gates Foundation; 2011 [accessed 2021 July 6]. https://www.gatesfoundation.org/ideas/annual-letters .
- Ehreth J. The global value of vaccination. Vaccine. 2003;21(7–8):596–7. doi:10.1016/s0264-410x(02)00623-0.
- Foundation TBMG. We are a nonprofit fighting poverty, disease, and inequity around the world. 2020 [accessed 2021 July 6]. https://www.gatesfoundation.org/ .
- Rémy V, Zöllner Y, Heckmann U. Vaccination: the cornerstone of an efficient healthcare system. J Mark Access Health Policy. 2015;3:27041. doi:10.3402/jmahp.v3.27041.
- Global Immunization Data. [accessed 2021 July 27]. https://www.who.int/immunization/monitoring_surveillance/global_immunization_data.pdf .
- Grenham A, Villafana T. Vaccine development and trials in low and lower-middle income countries: key issues, advances and future opportunities. Hum Vaccines Immunother. 2017;13(9):2192–99. doi:10.1080/21645515.2017.1356495.
- Drain PK, Parker RA, Robine M, Holmes KK, Bassett IV. Global migration of clinical research during the era of trial registration. PLoS ONE. 2018 [accessed 2021 July 6];13(6):e0199952. doi:10.1371/journal.pone.0192413.
- Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ Open. 2015;5(9):e008932–e. doi:10.1136/bmjopen-2015-008932.
- Gomez PL, Robinson JM, Rogalewicz JA. Vaccine manufacturing. Vaccines. 2013:44–57. doi:10.1016/B978-1-4557-0090-5.00019-7.
- Sheehy S BB, MRCP, DTM&H, Meyer J BM BCh, MRCP. Vaccine clinical trials be mandated? Virtual Mentor. 2012;14(1):35–38. doi:10.1001/virtualmentor.2012.14.1.pfor1-1201.
- Friedman DB, Foster C, Bergeron CD, Tanner A, Kim SH. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations. Am J Health Promot AJHP. 2015;29(5):332–38. doi:10.4278/ajhp.130514-QUAL-247.
- Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–06. doi:10.1016/j.vaccine.2020.09.041.
- Saluja T, Giri BR, Chaudhary S, Tamrakar D, Kanodia P, Palkar S, Vemula S, Chinaworapong S, Kim B, Gupta BP et al. Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: experience from Nepal. Hum Vaccines Immunother. 2021 :1–9. doi:10.1080/21645515.2020.1855955.
- Raheja D, Davila EP, Johnson ET, Deović R, Paine M, Rouphael N. Willingness to participate in vaccine-related clinical trials among older adults. Int J Environ Res Public Health. 2018;15(8):1743. doi:10.3390/ijerph15081743.
- ClinicalTrials.gov, US National Library of Medicine. Immune non-inferiority and safety study of a Vi-DT typhoid conjugate vaccine. [accessed 2021 Oct 31]. https://clinicaltrials.gov/ct2/results?cond=&term=NCT03933098&cntry=&state=&city=&dist= .
- International Clinical Trials Registry Platform (ICTRP). 2020. accessed 2021 Feb [accessed 2021 July 6]. https://www.who.int/clinical-trials-registry-platform/Clinical-Trials-in-Children .
- Pfizer. Clinical trials in children. 2021 [accessed 2021 July 6]. https://www.pfizer.com/science/clinical-trials/children .
- Organization WH. Pfizer BioNtech COVID-19 vaccine: what you need to know. 2020 [accessed 2021 July 6]. https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19–vaccine .
- Goldman RD, Staubli G, Cotanda CP, Brown JC, Hoeffe J, Seiler M, Gelernter R, Hall JE, Griffiths MA, Davis AL et al. Factors associated with parents’ willingness to enroll their children in trials for COVID-19 vaccination. Hum Vaccines Immunother. 2021;17(6):1607–11. doi:10.1080/21645515.2020.1834325.
- Akmatov MK, Jentsch L, Riese P, May M, Ahmed MW, Werner D, Rösel A, Prokein J, Bernemann I, Norman K, et al. Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccination. BMC Med Res Methodol. 2017;17:18. doi:10.1186/s12874-017-0302-z.
- Detoc M, Launay O, Dualé C, Mutter C, Le Huec JC, Lenzi N, Lucht F, Gagneux-Brunon A, Botelho-Nevers E. Barriers and motivations for participation in preventive vaccine clinical trials: experience of 5 clinical research sites. Vaccine. 2019 ;37(44):6633–39. doi:10.1016/j.vaccine.2019.09.048.
- Cobb EM, Singe DC, Davisr MW. Public interest in medical research participation: differences by volunteer status and study type. Clin Transl Sci. 2014;7(2):145–49. doi:10.1111/cts.12142.
- McMahon VA, Matthews S, Capper H, Chudleigh JB, McLachlan CS. Understanding decision and enabling factors influencing clinical trial participation in Australia: a view point. Asian Pac J Cancer Prev: APJCP. 2011;12:3153–56.